4xhigher odds of a psychotic disorder among daily users of high-potency marijuanaThe Lancet Psychiatry, 2019
19.3MAmericans meet clinical criteria for marijuana addiction, second only to alcohol2025 National Survey on Drug Use and Health
2xthe rate of serious suicidal thoughts among adult marijuana users vs all adults2023 NSDUH: 10.7% vs 5.0%
1 in 5schizophrenia cases among young men preventable by preventing marijuana addictionPsychological Medicine, 2023
Issues & Resources

Marijuana and mental health are now tied together in thousands of peer-reviewed studies. Today’s high-potency THC is linked to psychosis, depression, suicide, and addiction. Here is what the research says, with sources.

Reviewed September 2026 by SAM’s science team. Every figure links to its source below.

The short version
  1. Marijuana today averages four times the THC it did in 1995. Concentrates reach 99 percent.
  2. Daily use of high-potency products is linked to a four- to five-fold increase in psychosis, and the link holds across countries and decades.
  3. Adult users report suicidal thoughts at twice the national rate. Teen users face higher odds of depression and suicide attempts.
  4. About 30 percent of users develop an addiction. 19.3 million Americans have one now.
  5. Randomized trials do not support marijuana as a treatment for anxiety, depression, or PTSD. The Lancet Psychiatry says there is no universally safe level of use.

Why the old studies understate the risk

Most research on marijuana and mental health was done on a weaker drug than the one sold today. Average THC in DEA-seized marijuana quadrupled between 1995 and 2022. Concentrates, vapes, and dabs run 55 to 99 percent. A 30 percent THC product delivers roughly three times the THC of a 10 percent product, even after users adjust how much they take.

THC potency has quadrupled, and concentrates are in a different league

Average THC content by product and year

Average THC content of marijuana products, 1995 to 2017Bar chart. Seized marijuana flower averaged 4 percent THC in 1995 and 16 percent in 2022. Concentrates averaged 7 percent THC in 2008 and 56 percent in 2017. Vapes and dabs sold today reach up to 99 percent.Flower, 1995Flower, 2022Concentrates, 2008Concentrates, 2017Vapes & dabs, todayFlower 1995: 3.96% THCFlower 2022: 16.14% THCConcentrates 2008: 6.7% THCConcentrates 2017: 55.7% THCVapes and dabs: up to 99% THC4%16%7%56%up to 99%

Sources: DEA potency monitoring via NIDA (2024); Chandra et al. (2019); NIDA (2020). Compiled in SAM’s Impact Report 2026-27. Full data: Marijuana potency: how strong is weed today?

Use has changed too. In 2025, 21.4 million Americans used marijuana daily or nearly every day, more than smoke cigarettes daily and more than drink daily. The studies below come from populations using less, less often. The risk today is likely higher than they show.

Daily marijuana use now exceeds daily smoking and daily drinking

Americans aged 12 and older reporting daily or near-daily use, 2025, in millions

Daily or near-daily users of marijuana, cigarettes, and alcohol in the United States, 2025Bar chart. 21.4 million Americans use marijuana daily or near-daily, 19.9 million smoke cigarettes daily, and 17.2 million drink alcohol daily.MarijuanaCigarettesAlcoholMarijuana: 21.4 million daily or near-daily usersCigarettes: 19.9 million daily smokersAlcohol: 17.2 million daily drinkers21.4M19.9M17.2M

Source: SAMHSA, 2025 National Survey on Drug Use and Health, detailed tables.

Psychosis and schizophrenia

Does marijuana cause psychosis?

This is the most studied link between marijuana and mental health, and the most consistent. The pattern holds in Sweden in 1987, Europe in 2019, Denmark in 2023, and Ontario in 2025: the more THC and the more often, the higher the risk. Researchers describe marijuana as a contributing cause of psychosis, not the only cause.

4x

Daily users of high-potency marijuana had “four-times higher odds of psychosis” than never-users. The odds ratio was 4.8.

Di Forti et al., The Lancet Psychiatry, 2019. 11 sites, 901 first-episode psychosis patients, 1,237 controls.

241.6x

People treated in an ER for marijuana-induced psychosis were 241.6 times more likely to develop a schizophrenia-spectrum disorder within three years. Any marijuana-related ER visit: 14.3 times.

Canadian Medical Association Journal, 2025. 9.8 million Ontario residents.

up to 30%

Of schizophrenia cases among men 21 to 30 might have been prevented by preventing marijuana addiction. About one in five among young men overall.

Hjorthøj et al., Psychological Medicine, 2023. Danish national registry, 6.9 million people.

11x

Teens (12 to 19) who used marijuana had 11 times the risk of a psychotic disorder compared with non-users.

McDonald et al., Psychological Medicine, 2024.

47%

Of patients first treated for marijuana-induced psychosis were later diagnosed with a schizophrenia-spectrum disorder, often more than a year later.

Arendt et al., British Journal of Psychiatry, 2005. 535 cases.

2% to 8%

Share of Danish schizophrenia cases linked to marijuana addiction, 1995 to 2010, tracking rising potency and use.

Hjorthøj et al., JAMA Psychiatry, 2021.

“There is no universally safe level of cannabis use; thus, the only reliable way to avoid any risk for harm from using cannabis is abstinence.”The Lancet Psychiatry, 2026 review

Marijuana psychosis is not rare and not always temporary. Continued use after a first episode raises the odds of relapse and hospitalization. Stopping is protective.

Depression, anxiety, and suicide

Marijuana, depression, and suicide risk

The industry markets THC for stress and sleep. The population data point the other way. The studies below follow people over time and adjust for prior mental illness, so they are not simply catching people who were depressed to begin with.

Adult marijuana users report suicidal thoughts, plans, and attempts at about twice the national rate

Past-year rates among adults, 2023

Past-year marijuana usersAll adults

Suicidal thoughts, plans, and attempts among adult marijuana users versus all adults, 2023Grouped bar chart. Serious thoughts of suicide: 10.7 percent of marijuana users versus 5.0 percent of all adults. Made a suicide plan: 3.2 percent versus 1.4 percent. Attempted suicide: 1.4 percent versus 0.6 percent.Serious thoughtsMade a planAttemptedMarijuana users: 10.7%All adults: 5.0%Marijuana users: 3.2%All adults: 1.4%Marijuana users: 1.4%All adults: 0.6%10.7%5.0%3.2%1.4%1.4%0.6%

Source: SAMHSA, 2023 National Survey on Drug Use and Health. Compiled in SAM’s Impact Report 2026-27.

Teens who use marijuana face higher odds of depression and suicide as young adults

Pooled odds ratios from 11 longitudinal studies, 23,317 participants. 1.0 means no difference from non-users.

Odds ratios for depression, suicidal ideation, and suicide attempt in young adulthood among adolescent marijuana usersBar chart of odds ratios. Depression 1.37, suicidal ideation 1.50, suicide attempt 3.46, compared with a baseline of 1.0 for non-users.DepressionSuicidal ideationSuicide attempt1.0 (no difference)Depression: OR 1.37 (95% CI 1.16 to 1.62)Suicidal ideation: OR 1.50 (95% CI 1.11 to 2.03)Suicide attempt: OR 3.46 (95% CI 1.53 to 7.84)1.371.503.46

Source: Gobbi et al., JAMA Psychiatry, 2019. Anxiety (OR 1.18) was not statistically significant.

46% and 85%

Higher odds of suicidal ideation and of a suicide attempt among adolescents who used marijuana, after accounting for pre-existing depression.

Drug and Alcohol Dependence, 2025 (Sorbonne)

~10x

Risk of death by suicide within five years among people who received hospital care for marijuana addiction. Overall mortality was nearly three times higher. More on marijuana deaths.

JAMA Network Open, 2025. 11.6 million Ontario residents.

24% vs 8.5%

Adults with marijuana addiction who had a major depressive episode in the past year, compared with all adults. More than half (52.5%) had a mental illness.

SAMHSA, 2023 NSDUH

34% and 24%

Higher risk of a later depressive disorder and of an anxiety disorder among teens who used marijuana, and roughly double the risk of a new psychotic or bipolar disorder.

Young-Wolff et al., JAMA Health Forum, February 2026. 463,396 California adolescents followed to age 25.

Colorado is the cautionary tale. Since legalization, suicides among adolescents aged 15 to 19 have nearly doubled, and marijuana is now the most common substance found in the toxicology of Colorado youth who die by suicide. Before legalization it was alcohol.

The developing brain

How marijuana affects the teenage brain

The brain is not finished until about age 25, and THC acts on the system that wires it. Every major finding on youth use points the same direction: earlier and heavier use, worse outcomes, and some of the damage does not reverse. For the state-by-state numbers on teen use, see Youth Marijuana Use.

8 IQ points

Average decline from childhood to adulthood among persistent adolescent-onset users. Points lost did not return after quitting.

Meier et al., PNAS, 2012 (Dunedin cohort)

51%

Higher chance of mental health problems, and 86 percent higher chance of physical health problems, among people who began at least monthly use before age 15.

McGill University, JAMA Network Open, 2025

63% and 68%

Of heavy lifetime users and recent users showed reduced brain activity on working-memory tasks in the largest neuroimaging study of its kind.

University of Colorado, JAMA Network Open, 2025

2x

The odds of dropping out of high school among adolescent users, plus 39 percent higher odds of lower grades and 28 percent lower odds of attending university.

Chan et al., 2024 meta-analysis

2 to 4x

Greater odds of major depression, suicidal ideation, trouble concentrating, truancy, and arrest among teens with even non-disordered use.

Sultan et al., Columbia University, JAMA Network Open, 2023

79% and 146%

More likely to have an anxiety disorder, and PTSD, among children whose mothers had marijuana addiction during pregnancy. See marijuana during pregnancy.

Journal of Affective Disorders, 2025

Addiction

Is marijuana addictive?

Yes. That is the National Institute on Drug Abuse’s position, and the numbers are large. About 30 percent of users develop a use disorder. Starting before 18 raises the odds four- to seven-fold. Higher potency means higher risk, and the risk is highest for the youngest users.

19.3 million

Americans met clinical criteria for marijuana use disorder in 2025, up 2.6 million since 2021. One in three users. One in seven adults aged 18 to 25.

SAMHSA, 2025 NSDUH

47%

Of regular users experience withdrawal when they stop: irritability, insomnia, anxiety, cravings.

Bahji et al., JAMA Network Open, 2020 meta-analysis

1.7x

Higher risk of a dementia diagnosis within five years among adults over 45 who needed hospital care for marijuana. Such visits rose 26.7-fold among people 65 and older from 2008 to 2021.

JAMA Neurology, 2025. 6.1 million Ontario adults.

Fewer treated

Even as more young people in legal states need treatment for marijuana addiction, fewer are receiving it.

Mennis et al., 2023

The medical claim

Does marijuana treat anxiety, depression, or PTSD?

No. The claim that marijuana relieves anxiety, depression, or PTSD is the industry’s oldest sales pitch. The randomized trials do not support it.

JAMA, 2025

“Evidence from randomized clinical trials does not support the use of cannabis or cannabinoids for most conditions” for which they are promoted.

Hsu et al., Therapeutic Use of Cannabis and Cannabinoids, JAMA, November 2025

Randomized trial

People randomly assigned a medical marijuana card had “increased incidence and severity of CUD and resulted in no significant improvement in pain, anxiety, or depressive symptoms.”

Gilman et al., JAMA Network Open, 2022

PTSD

Two studies of military personnel with PTSD found elevated suicidal thoughts and behaviors among those using marijuana.

Allan et al., Depression and Anxiety, 2019; Gentes et al., 2016

83 studies

“Very little evidence” that cannabinoids improve depressive disorders, anxiety disorders, ADHD, Tourette syndrome, PTSD, or psychosis.

Black et al., The Lancet Psychiatry, 2019 systematic review

Real people

The numbers are families

Johnny Stack with his mother, Laura Stack

Johnny Stack, 19, ColoradoDeveloped marijuana-induced psychosis after dabbing high-potency concentrates. Died by suicide in 2019. His mother Laura founded Johnny’s Ambassadors.
Andy Zorn with his mother, Sally Schindel

Andy Zorn, 31, ArizonaA five-year spiral into marijuana addiction and mental illness. His note read “Marijuana killed my soul.” His mother Sally tells his story.
“I once believed marijuana was relatively harmless.”Cindy Gresham, Haley’s mother
Haley Gresham, 15Died by suicide after her struggle with today’s high-potency THC products. Her mother Cindy testified for SAM at the 2026 DEA rescheduling hearing.

More stories from families, and how to share yours through the Parent Action Network.

Policy

What SAM is calling for

  1. Potency caps. Vermont and Connecticut cap concentrates at 60 percent and flower at 30 percent. Every legal state should, and none should sell 99 percent THC to anyone.
  2. Mental health warning labels on every THC product, modeled on tobacco: psychosis, addiction, suicide risk, and the developing brain.
  3. A pause on new legalization until the mental health data from Colorado, Washington, and Canada are honestly reckoned with.
  4. Real-time public data on marijuana-related psychiatric emergencies, psychosis admissions, potency, and treatment demand, reported by every legal state.
  5. No federal rescheduling that hands the industry tax breaks and a “medicine” label the trials do not support.
  6. Close the hemp loophole so intoxicating THC is not sold in gas stations without any of the above.

Where to go next

Parents

Join the Parent Action Network for talking points and the warning signs of marijuana psychosis.

Clinicians and counselors

Download the one-pagers and book a SAM training.

Legislators and staff

Read the 2026-27 Impact Report and the Local Control Toolkit.

Journalists

Every figure has a primary source below. Interviews and data: info@learnaboutsam.org.

Marijuana and mental health: frequently asked questions

Does marijuana cause schizophrenia?

Marijuana use is strongly and consistently linked to schizophrenia, and studies that follow people over time show use comes first. Daily users of high-potency products have about four times the odds of a psychotic disorder. Danish researchers estimate up to 30 percent of schizophrenia cases among young men could be prevented by preventing marijuana addiction. Scientists describe it as a contributing cause, not the only cause.

Can marijuana help with anxiety or depression?

Randomized trials say no. A 2025 review in JAMA found trial evidence does not support marijuana for most conditions it is promoted for. A randomized trial that gave people medical marijuana cards found no improvement in anxiety or depression and an increase in addiction. Population studies link marijuana use to higher rates of depression and anxiety later on.

How common is marijuana addiction?

About 30 percent of users develop a use disorder, according to NIDA. In 2025, 19.3 million Americans met clinical criteria, more than for any drug except alcohol. Starting before age 18 raises the risk four- to seven-fold.

Is today’s marijuana really that different?

Yes. Average THC in seized marijuana rose from about 4 percent in 1995 to over 16 percent in 2022. Concentrates and vapes run 55 to 99 percent. Psychosis and addiction risk rise with potency, and most older research was done on a much weaker product.

What are the signs of marijuana psychosis?

Paranoia, hearing or seeing things that are not there, disorganized thinking, and detachment from reality, usually during or after heavy use of high-potency products. It can last days or become a lasting disorder. Anyone with these symptoms should stop using and see a doctor. In an emergency, call 911 or 988.

Does SAM want to arrest people who use marijuana?

No. SAM opposes incarceration for use and supports treatment and prevention. What we oppose is a commercial industry selling high-potency THC with no potency limits, no honest warnings, and no accountability for the mental health harms documented here.

Marijuana today is a high-potency drug with documented mental health harms. Get the facts to the people who need them.

Download the Impact ReportJoin the Parent Action NetworkBook a training

Sources

  1. Di Forti M, et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI). The Lancet Psychiatry. 2019;6(5):427-436.
  2. Canadian Medical Association Journal. 2025;197(27). Emergency department visits for cannabis use and schizophrenia (Ontario).
  3. Hjorthøj C, et al. Association between cannabis use disorder and schizophrenia stronger in young males than in females. Psychological Medicine. 2023.
  4. Hjorthøj C, et al. Development over time of the population-attributable risk fraction for cannabis use disorder in schizophrenia in Denmark. JAMA Psychiatry. 2021.
  5. McDonald AJ, et al. Age-dependent association of cannabis use with risk of psychotic disorder. Psychological Medicine. 2024.
  6. Arendt M, et al. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders. British Journal of Psychiatry. 2005.
  7. The Lancet Psychiatry. 2026. Review of cannabis use and mental health outcomes (“no universally safe level of cannabis use”).
  8. SAMHSA. 2023 and 2025 National Survey on Drug Use and Health, detailed tables.
  9. Gobbi G, et al. Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood. JAMA Psychiatry. 2019;76(4):426-434.
  10. Drug and Alcohol Dependence, 2025 (Sorbonne). Adolescent cannabis use and suicidality.
  11. JAMA Network Open, 2025. Cannabis use disorder and mortality (Ontario, 11.6 million).
  12. Young-Wolff KC, et al. Adolescent cannabis use and risk of psychotic, bipolar, depressive, and anxiety disorders. JAMA Health Forum. February 2026.
  13. Myran DT, et al. Changes in incident schizophrenia diagnoses associated with cannabis use disorder after cannabis legalization. JAMA Network Open. 2025;8(2):e2457868.
  14. Meier MH, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. PNAS. 2012.
  15. McGill University. JAMA Network Open. 2025. Early frequent cannabis use and health outcomes.
  16. University of Colorado. JAMA Network Open. 2025. Cannabis use and brain function during working memory.
  17. Chan GCK, et al. Adolescent cannabis use and educational outcomes: meta-analysis. 2024.
  18. Sultan RS, et al. Nondisordered cannabis use among US adolescents. JAMA Network Open. 2023.
  19. Journal of Affective Disorders, 2025. Prenatal cannabis use disorder and offspring anxiety and PTSD.
  20. National Institute on Drug Abuse. Is marijuana addictive?
  21. Bahji A, et al. Prevalence of cannabis withdrawal symptoms. JAMA Network Open. 2020.
  22. JAMA Neurology, 2025. Cannabis-related acute care and dementia risk (Ontario).
  23. Mennis J, et al. 2023. Treatment admissions for cannabis use disorder.
  24. Hsu G, et al. Therapeutic use of cannabis and cannabinoids. JAMA. November 2025.
  25. Gilman JM, et al. Effect of medical marijuana card ownership on pain, insomnia, and affective disorder symptoms. JAMA Network Open. 2022.
  26. Allan NP, et al. Depression and Anxiety. 2019;36(11); Gentes EL, et al. 2016.
  27. Black N, et al. Cannabinoids for the treatment of mental disorders. The Lancet Psychiatry. 2019.
  28. USC and Kaiser Permanente. Substance Use & Misuse. 2025. DOI 10.1080/10826084.2025.2505145.
  29. Cerdá M, et al. JAMA Psychiatry. 2020. Recreational marijuana legalization and cannabis use disorder.
  30. Pawar AB, et al. Journal of the American Academy of Child and Adolescent Psychiatry. 2024;63(11).
  31. Mass General Brigham, January 2026. Adolescent psychiatric emergencies after Massachusetts commercialization.
  32. Xu et al. European Journal of Health Economics. 2025. THC intake by product potency.
  33. NIDA. Cannabis potency data, 2024; Chandra S, et al. 2019; NIDA 2020.
  34. SAM. Lessons Learned from State Marijuana Legalization: Impact Report 2026-2027.

Our family of organizations